about
αV integrins in angiogenesis and cancerGenome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinomaThe ZNF304-integrin axis protects against anoikis in cancerInferring Growth Control Mechanisms in Growing Multi-cellular Spheroids of NSCLC Cells from Spatial-Temporal Image DataIntegrins as Therapeutic Targets for Respiratory DiseasesPolymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment.Integrated analyses of copy number variations and gene expression in lung adenocarcinomaThe soybean-derived peptide lunasin inhibits non-small cell lung cancer cell proliferation by suppressing phosphorylation of the retinoblastoma protein.Fibroblast-Derived Extracellular Matrices: An Alternative Cell Culture System That Increases Metastatic Cellular PropertiesAlteration of Pituitary Tumor Transforming Gene-1 Regulates Trophoblast Invasion via the Integrin/Rho-Family Signaling PathwayThe fibronectin III-1 domain activates a PI3-Kinase/Akt signaling pathway leading to αvβ5 integrin activation and TRAIL resistance in human lung cancer cells.Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent mannerComparing the expression of integrins αvβ3, αvβ5, αvβ6, αvβ8, fibronectin and fibrinogen in human brain metastases and their corresponding primary tumors.Integrin-Targeted Hybrid Fluorescence Molecular Tomography/X-ray Computed Tomography for Imaging Tumor Progression and Early Response in Non-Small Cell Lung Cancer.Critical role of RAGE in lung physiology and tumorigenesis: a potential target of therapeutic intervention?Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors.Longitudinal expression analysis of αv integrins in human gliomas reveals upregulation of integrin αvβ3 as a negative prognostic factor.Early recognition of lung cancer by integrin targeted imaging in K-ras mouse model.MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO).Integrin Targeting and Toxicological Assessment of Peptide-Conjugated Liposome Delivery Systems to Activated Endothelial Cells.
P2860
Q26851768-D79DE9EA-7A13-4108-A370-A372BEEC61CAQ27324064-82154C5F-ACA2-4AC6-B144-B709E85E9098Q28115264-9BD68F7C-2B6E-4603-8B16-D183A77C4702Q31044284-49B2C18C-EAF9-4035-AFDD-49EEC9AF1EE2Q33668635-BF021849-2B03-4897-B028-A81D2B59668DQ33824400-6E625A24-0AA3-4F00-9ACC-9A03C5089BFFQ34026325-450C3D75-96C8-4FFA-AC09-5A6043D5F8E3Q34459042-E59ADA65-2DAF-4552-8FCB-E0158FAEAA3DQ35775737-BFAF7DA7-D9DC-4D48-BBDA-335AEB666D5BQ35930651-B199AAE1-5BBC-4073-9CED-6C56BBE1BA13Q36092975-45C366F6-99FD-47FE-9EBB-C43F536D1D89Q36435764-6854DF60-25A5-45DC-A70B-DC2D4519770DQ37349452-AC4E102C-768E-4453-9BB8-125E651BBDA9Q37505641-9D295915-6D43-40DF-A918-4FE5FFDD6FBAQ38150990-00FE0F28-3AE2-4B66-A480-165EFD9239E9Q38161726-0FD8CFA1-3CD8-4F8D-BFBF-D201BC579096Q38398188-E7CFA42D-2EFC-4C91-935C-FCBB05CDE05AQ38934764-E8E321DC-BA1E-4DEB-A0A0-CF0C826BB616Q41296584-FA1E13D2-6583-4C6E-9402-5AB5A28ACCE4Q49141898-17FB8F29-5B45-42CC-8192-8F38D9A9F640Q51130308-D3FA139C-6F31-47EA-A4E2-BDB8DF944EA2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Integrin signaling and lung cancer.
@en
Integrin signaling and lung cancer.
@nl
type
label
Integrin signaling and lung cancer.
@en
Integrin signaling and lung cancer.
@nl
prefLabel
Integrin signaling and lung cancer.
@en
Integrin signaling and lung cancer.
@nl
P2860
P50
P356
P1476
Integrin signaling and lung cancer
@en
P2093
Chiara Sandri
Francesca Caccavari
P2860
P304
P356
10.4161/CAM.4.1.10976
P577
2010-01-16T00:00:00Z